Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AGfiledCriticalSchering AG
Publication of ES249740A1publicationCriticalpatent/ES249740A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Procedure for obtaining Rºntgen contrast media, particularly applicable perorally for cholecystography, characterized in that B- (dimethylaminomethylene-naphenyl) -propionic acids of the general formula are used as the shading substance. ** (See formula) ** wherein R represents hydrogen or an alkyl or cycloalkyl with up to 6 carbon atoms and n the numbers 2-3. (Machine-translation by Google Translate, not legally binding)
ES0249740A1958-06-201959-05-29Procedure for obtaining rºntgen contrast media (Machine-translation by Google Translate, not legally binding)
ExpiredES249740A1
(en)
Procedure for the obtaining of new esters 1-alkyl-4-piperidilic O-substitute benzoic acids (Machine-translation by Google Translate, not legally binding)
Procedure for obtaining new derivatives of piperidil-2 phenylmethanols and their added salts (Machine-translation by Google Translate, not legally binding)